⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TARA News
Protara Therapeutics, Inc. Common Stock
Protara Announces Proposed Public Offering
globenewswire.com
TARA
Protara Therapeutics Announces Updated Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naïve NMIBC Patients
globenewswire.com
TARA
Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naïve NMIBC Patients on Wednesday, December 3, 2025
globenewswire.com
TARA
Protara Therapeutics Announces Positive Interim Results Demonstrating Robust Responses in the Ongoing Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations
globenewswire.com
TARA
Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations on Wednesday, November 19, 2025
globenewswire.com
TARA
Protara Therapeutics to Present New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naïve NMIBC Patients at the 26th Annual Meeting of the Society of Urologic Oncology
globenewswire.com
TARA
Protara Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update
globenewswire.com
TARA
Protara Therapeutics Named a 2026 Best Places to Work Winner by BioSpace
globenewswire.com
TARA
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
TARA